Oramed Pharmaceuticals
ORMP
#9104
Rank
S$0.11 B
Marketcap
$2.83
Share price
-2.78%
Change (1 day)
-19.77%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): S$33.12 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of S$9.58 Million, an increase over its 2022 earnings that were of -S$49.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$33.12 M245.56%
2023 S$9.58 M-119.45%
2022 -S$49.29 Million39.17%
2021 -S$35.42 Million73.93%
2020 -S$20.37 Million18.53%
2019 -S$17.18 Million-16.62%
2018 -S$20.61 Million38.32%
2017 -S$14.9 Million12.51%
2016 -S$13.24 Million25.01%
2015 -S$10.59 Million18.18%
2014 -S$8.97 Million39.72%
2013 -S$6.42 Million46.4%
2012 -S$4.39 Million128.32%
2011 -S$1.92 Million-51.47%
2010 -S$3.96 Million35.21%
2009 -S$2.93 Million
2007 -S$4.6 Million607.04%
2006 -S$0.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.68 Billion-2,147.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$25.48 B 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
S$10.68 B 32,128.38%๐Ÿ‡ซ๐Ÿ‡ท France
-S$13.07 Million-139.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-S$0.27 Billion-913.22%๐Ÿ‡บ๐Ÿ‡ธ USA